Laura D'Erasmo | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Sex-related differences in response to lomitapide in HoFH: A subanalysis of the Pan-European Lomitapide retrospective observational study	ATHEROSCLEROSIS	2025
Renal Safety Assessment of Lipid-Lowering Drugs: Between Old Certainties and New Questions	DRUGS	2025
The vicious circle of chronic kidney disease and hypertriglyceridemia: What is first, the hen or the egg?	ATHEROSCLEROSIS	2025
Lipid-Lowering Therapy and Cardiovascular Prevention in Elderly	DRUGS	2025
Long-term experience with lomitapide treatment in patients with homozygous familial hypercholesterolemia: Over 10 years of efficacy and safety data	JOURNAL OF CLINICAL LIPIDOLOGY	2025
Lomitapide-induced fatty liver is a reversible condition: evidence from a case of familial chylomicronemia syndrome	JOURNAL OF CLINICAL LIPIDOLOGY	2025
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia	JAMA CARDIOLOGY	2024
Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries	EUROPEAN JOURNAL OF INTERNAL MEDICINE	2024
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry	EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY	2024
Is bempedoic acid a drug for female subjects? Preliminary analysis in an Italian cohort	ATHEROSCLEROSIS	2024
Effect of Cholesterol-Lowering Variants in ANGPTL3 and APOB Genes on Liver Disease	JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY	2024
Protocol for oil red O staining of low-density lipoproteins for in vivo cell treatment	STAR PROTOCOLS	2024
How ANGPTL3 Inhibition Will Help Our Clinical Practice?	CURRENT ATHEROSCLEROSIS REPORTS	2023
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia.	LIVER INTERNATIONAL	2023
Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography study	LA RADIOLOGIA MEDICA	2023
ANGPTL3 Deficiency and Risk of Hepatic Steatosis	CIRCULATION	2023
Real‐World Effectiveness of PCSK9 Inhibitors in Reducing LDL‐C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries	JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE	2023
ANGPTL3 Deficiency and Risk of Hepatic Steatosis	CIRCULATION	2023
Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis	BRITISH JOURNAL OF CLINICAL PHARMACOLOGY	2022
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study	THE LANCET	2022

Progetti di Ricerca

Studio multicentrico osservazionale di valutazione dell'efficacia della terapia con lomitapide nel migliorare il profilo lipidico e ridurre l'incidenza di eventi cardiovascolari in pazienti affetti da ipercolesterolemia familiare omozigote: analisi ...